|
US4820834A
(en)
|
1984-06-26 |
1989-04-11 |
Merck & Co., Inc. |
Benzodiazepine analogs
|
|
US4735941A
(en)
|
1986-12-23 |
1988-04-05 |
Merck & Co., Inc. |
1,4-benzodiazepines with 5- and 6-membered heterocyclic rings, useful as gastrointestinal and CNS agents
|
|
EP0304223A3
(en)
|
1987-08-17 |
1990-10-24 |
Merck & Co. Inc. |
Beta-carbolines as cholecy-stokinin and gastrin antagonist
|
|
US5166151A
(en)
|
1988-03-25 |
1992-11-24 |
Merck & Co., Inc. |
2-Benzazepines with 5- and 6-membered heterocyclic rings, compositions and medical methods of use thereof
|
|
US5032604A
(en)
|
1989-12-08 |
1991-07-16 |
Merck & Co., Inc. |
Class III antiarrhythmic agents
|
|
CA2032427A1
(en)
|
1989-12-18 |
1991-06-19 |
Mark G. Bock |
Benzodiazepines analogs
|
|
CA2032226A1
(en)
|
1989-12-18 |
1991-06-19 |
Mark G. Bock |
Benzodiazepine analogs
|
|
US5324726A
(en)
|
1989-12-18 |
1994-06-28 |
Merck & Co., Inc. |
Benzodiazepine analogs
|
|
US5041453A
(en)
|
1990-05-30 |
1991-08-20 |
Rhone-Poulenc Rorer Pharmaceuticals Inc. |
Quinolinyl-benzoheterobicyclic derivatives as antagonists of leukotriene D4
|
|
US5095031A
(en)
|
1990-08-20 |
1992-03-10 |
Abbott Laboratories |
Indole derivatives which inhibit leukotriene biosynthesis
|
|
CA2056809A1
(en)
|
1990-12-07 |
1992-06-08 |
Mark G. Bock |
Benzodiazepine analogs
|
|
US5185331A
(en)
|
1991-05-14 |
1993-02-09 |
Merck & Co., Inc. |
Triazolobenzodiazepines
|
|
CA2068500A1
(en)
|
1991-05-14 |
1992-11-15 |
Roger M. Freidinger |
1,4-benzodiazepines with 5- and 6-membered heterocyclic rings
|
|
US5206237A
(en)
|
1991-05-14 |
1993-04-27 |
Merck & Co., Inc. |
Benzodiazepine analogs
|
|
US5210082A
(en)
|
1991-05-16 |
1993-05-11 |
Merck & Co., Inc. |
2-benzazepines with 5- and 6-membered heterocyclic rings to treat pain and anxiety disorders
|
|
CA2071092A1
(en)
|
1991-06-14 |
1992-12-15 |
Roger M. Freidinger |
1,4-benzodiazepines with 5-membered heterocyclic rings
|
|
EP0523845A3
(en)
|
1991-06-14 |
1993-11-18 |
Merck & Co Inc |
New benzodiazepine analogs
|
|
US5177071A
(en)
|
1991-06-17 |
1993-01-05 |
Merck & Co., Inc. |
1,4-benzodiazepines with 6-membered heterocyclic rings to treat panic and anxiety disorder
|
|
MY110227A
(en)
|
1991-08-12 |
1998-03-31 |
Ciba Geigy Ag |
1-acylpiperindine compounds.
|
|
GB9117852D0
(en)
|
1991-08-19 |
1991-10-09 |
Merck Sharp & Dohme |
Therapeutic agents
|
|
US6323212B1
(en)
|
1992-01-23 |
2001-11-27 |
Toray Industries, Inc. |
Morphinan derivative and its pharmaceutical applications
|
|
EP0642498A1
(en)
|
1992-05-28 |
1995-03-15 |
Pfizer Inc. |
NEW $i(N)-ARYL AND $i(N)-HETEROARYLUREA DERIVATIVES AS INHIBITORS OF ACYL COENZYME A:CHOLESTEROL ACYL TRANSFERASE (ACAT)
|
|
WO1994008962A1
(en)
|
1992-10-14 |
1994-04-28 |
Merck & Co., Inc. |
Fibrinogen receptor antagonists
|
|
EP0663401B1
(en)
|
1993-07-23 |
2000-06-07 |
Toray Industries, Inc. |
Morphinan derivative and medicinal use
|
|
AU674613B2
(en)
|
1993-09-28 |
1997-01-02 |
Otsuka Pharmaceutical Co., Ltd. |
Quinoxaline derivative as antidiabetic agent
|
|
GB9408577D0
(en)
|
1994-04-29 |
1994-06-22 |
Fujisawa Pharmaceutical Co |
New compound
|
|
FR2725985B1
(fr)
|
1994-10-21 |
1996-11-15 |
Adir |
Nouveaux composes tricycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
|
|
FR2734814B1
(fr)
|
1995-05-31 |
1997-07-04 |
Adir |
Nouveaux composes alkoxy-aryles, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
|
|
JPH11513684A
(ja)
|
1995-10-19 |
1999-11-24 |
メルク エンド カンパニー インコーポレーテッド |
１６−置換−６−アザ−ステロイド５α−レダクターゼ阻害剤
|
|
US5821261A
(en)
|
1995-12-08 |
1998-10-13 |
Merck & Co., Inc. |
Substituted saturated aza heterocycles as inhibitors of nitric oxide synthase
|
|
ATE359076T1
(de)
|
1996-11-25 |
2007-05-15 |
Toray Industries |
Mittel gegen juckreiz
|
|
WO1998049150A1
(en)
|
1997-04-25 |
1998-11-05 |
Takeda Chemical Industries, Ltd. |
Triazine derivatives, their production and agrochemical composition
|
|
US6372755B2
(en)
|
1997-07-11 |
2002-04-16 |
Toray Industries, Inc. |
Stable medicinal compositions containing 4,5-epoxymorphinan derivatives
|
|
WO1999005146A1
(en)
|
1997-07-25 |
1999-02-04 |
Toray Industries, Inc. |
Hyponatremia remedies
|
|
JP4359711B2
(ja)
|
1997-09-02 |
2009-11-04 |
東レ株式会社 |
薬物依存症治療薬
|
|
FR2778662B1
(fr)
|
1998-05-12 |
2000-06-16 |
Adir |
Nouveaux composes cycliques substitues, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
|
|
WO1999059586A1
(en)
|
1998-05-19 |
1999-11-25 |
Regents Of The University Of California |
Thiazolidine and oxazolidine derivatives for the treatment of acute myocardial infarction and inhibition of cardiomyocyte apoptosis
|
|
JP2000053572A
(ja)
|
1998-08-11 |
2000-02-22 |
Toray Ind Inc |
ＯＲＬ１（ｏｐｉｏｉｄ ｏｒｐｈａｎ）受容体拮抗薬
|
|
JP2003524598A
(ja)
|
1998-09-04 |
2003-08-19 |
アルタナ ファルマ アクチエンゲゼルシャフト |
新規ピラノセン
|
|
ES2211172T3
(es)
|
1998-09-25 |
2004-07-01 |
Astrazeneca Ab |
Derivados de benzamida y su utilizacion como inhibidores de citoquinas.
|
|
ATE302005T1
(de)
|
1998-12-18 |
2005-09-15 |
Bristol Myers Squibb Pharma Co |
N-ureidoalkylpiperidine als modulatoren der aktivität der chemokinrezeptoren
|
|
CA2348740A1
(en)
|
1998-12-23 |
2000-07-06 |
Ruth R. Wexler |
Thrombin or factor xa inhibitors
|
|
IL145922A0
(en)
|
1999-04-28 |
2002-07-25 |
Aventis Pharma Gmbh |
Di-aryl acid derivatives as ppar receptor ligands
|
|
DE60039444D1
(de)
|
1999-08-24 |
2008-08-21 |
Toray Industries |
Heilmittel für neuropathischen schmerz und versuchstier-modelle des neuropathischen schmerzes
|
|
JP2001163784A
(ja)
|
1999-12-06 |
2001-06-19 |
Toray Ind Inc |
角膜または結膜用止痒剤
|
|
WO2001051456A2
(en)
|
2000-01-13 |
2001-07-19 |
Tularik Inc. |
Antibacterial agents
|
|
AU2001273040A1
(en)
|
2000-06-27 |
2002-01-08 |
Du Pont Pharmaceuticals Company |
Factor xa inhibitors
|
|
US6545152B1
(en)
|
2000-07-18 |
2003-04-08 |
Parker Hughes Institute |
R-isomers of nonnucleoside inhibitors
|
|
CA2442423C
(en)
|
2001-03-30 |
2009-11-03 |
Toray Industries, Inc. |
Therapeutic drug for psychoneurotic disorders
|
|
EP1402899A4
(en)
|
2001-05-08 |
2009-03-11 |
Toray Industries |
MEANS FOR THE TREATMENT OF SEPSIS
|
|
SE0101978D0
(sv)
|
2001-06-01 |
2001-06-01 |
Astrazeneca Ab |
New compounds
|
|
MY130373A
(en)
|
2001-10-29 |
2007-06-29 |
Malesci Sas |
Linear basic compounds having nk-2 antagonist activity and formulations thereof
|
|
US7718663B2
(en)
|
2002-04-26 |
2010-05-18 |
Nippon Shinyaku Co., Ltd. |
Quinazoline derivatives and medicaments
|
|
EP1578429A4
(en)
|
2002-05-22 |
2006-12-06 |
Smithkline Beecham Corp |
PROTEASE INHIBITORS
|
|
CL2003001415A1
(es)
|
2002-07-12 |
2005-01-07 |
Janssen Pharmaceutica Nv |
Compuestos d derivados de naftil, quinolinil e isoquinolinil urea; composicion farmaceutica; y uso en el tratamiento y prevencion de condiciones de dolor y en el sibndrome del colon irritable y condiciones asociadas.
|
|
AU2003261756A1
(en)
|
2002-08-28 |
2004-03-29 |
Toray Industries, Inc. |
Acrylamide derivatives
|
|
JP2004083511A
(ja)
|
2002-08-28 |
2004-03-18 |
Yamanouchi Pharmaceut Co Ltd |
アクリルアミド誘導体
|
|
JP2006526608A
(ja)
*
|
2003-06-05 |
2006-11-24 |
ワーナー−ランバート カンパニー リミティド ライアビリティー カンパニー |
Ｐｉ３ｋ活性を有する治療薬としてのテトラゾールベンゾフランカルボキシアミド
|
|
WO2005004810A2
(en)
|
2003-07-02 |
2005-01-20 |
Merck & Co., Inc. |
Arylsulfonamide derivatives
|
|
GB0324498D0
(en)
|
2003-07-21 |
2003-11-26 |
Aventis Pharma Inc |
Heterocyclic compounds as P2X7 ion channel blockers
|
|
CA2536253A1
(en)
|
2003-08-20 |
2005-03-03 |
Vertex Pharmaceuticals Incorporated |
Aminofurazan compounds useful as protein kinase inhibitors
|
|
CA2542220A1
(en)
|
2003-10-22 |
2005-05-06 |
Eli Lilly And Company |
Novel mch receptor antagonists
|
|
KR20060115396A
(ko)
|
2003-10-28 |
2006-11-08 |
버텍스 파마슈티칼스 인코포레이티드 |
이온 채널 조절인자로서 유용한 벤즈이미다졸
|
|
WO2005051938A1
(en)
|
2003-11-20 |
2005-06-09 |
Eli Lilly And Company |
Vitamin d receptor modulators
|
|
UA89035C2
(ru)
|
2003-12-03 |
2009-12-25 |
Лео Фарма А/С |
Эфиры гидроксамовых кислот и их фармацевтическое применение
|
|
TW200600494A
(en)
|
2004-03-08 |
2006-01-01 |
Chugai Pharmaceutical Co Ltd |
Bisphenyl compounds useful as vitamin d3 receptor agonists
|
|
JP2007535551A
(ja)
|
2004-04-28 |
2007-12-06 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
Ｒｏｃｋおよび他のプロテインキナーゼの阻害剤として有用な組成物
|
|
MX2007011234A
(es)
|
2005-03-14 |
2007-11-12 |
Transtech Pharma Inc |
Derivados de benzazol, composiciones y metodos de uso en la forma de inhibidores de b-secretasa.
|
|
EP1704860B1
(en)
|
2005-03-24 |
2010-10-27 |
Rottapharm S.P.A. |
Benzamidine derivatives for treatment and prevention of mucositis
|
|
WO2006133459A1
(en)
|
2005-06-09 |
2006-12-14 |
Vertex Pharmaceuticals Incorporated |
Indane derivatives as modulators of ion channels
|
|
WO2007026720A1
(ja)
|
2005-08-31 |
2007-03-08 |
Taisho Pharmaceutical Co., Ltd. |
縮環ピラゾール誘導体
|
|
US7897766B2
(en)
|
2005-09-23 |
2011-03-01 |
Abbott Laboratories |
Amino-aza-adamantane derivatives and methods of use
|
|
ES2383090T3
(es)
|
2005-10-12 |
2012-06-18 |
Vertex Pharmaceuticals, Inc. |
Derivados de bifenilo como moduladores de los canales iónicos dependientes de voltaje
|
|
NZ593074A
(en)
|
2005-12-21 |
2012-04-27 |
Vertex Pharma |
sulfonamide-pyrrolidone derivatives as Modulators of Ion Channels
|
|
US7790707B2
(en)
|
2006-03-21 |
2010-09-07 |
Epix Pharmaceuticals Inc. |
S1P receptor modulating compounds and use thereof
|
|
TW200815351A
(en)
|
2006-05-02 |
2008-04-01 |
Astrazeneca Ab |
Novel compounds
|
|
EP2051964A4
(en)
|
2006-07-28 |
2012-03-07 |
Univ Connecticut |
INHIBITORS OF FATTY ACID AMIDHYDROLASE
|
|
JP2010502618A
(ja)
|
2006-08-31 |
2010-01-28 |
アリーナ ファーマシューティカルズ， インコーポレイテッド |
セロトニン５−ｈｔ２ａ受容体のモジュレータとしてのベンゾフラン誘導体
|
|
PE20080888A1
(es)
|
2006-10-18 |
2008-08-26 |
Novartis Ag |
COMPUESTOS HETEROCICLICOS COMO INHIBIDORES DE LA ACIL-TRANSFERASA DE ACIL-CoA-DIACIL-GLICEROL 1 (DGAT1)
|
|
WO2008133297A1
(ja)
|
2007-04-24 |
2008-11-06 |
Toray Industries, Inc. |
ジスキネジアの治療または予防剤
|
|
JP5099127B2
(ja)
|
2007-04-26 |
2012-12-12 |
東レ株式会社 |
４，５−エポキシモルヒナン誘導体を含有する安定な固形製剤
|
|
WO2008156573A1
(en)
|
2007-06-12 |
2008-12-24 |
Provid Pharmaceuticals, Inc. |
Kinase inhibitors, compositions thereof, and methods of use therewith
|
|
CA2934114A1
(en)
|
2007-06-12 |
2008-12-18 |
Achaogen, Inc. |
Antibacterial agents
|
|
MX2010003660A
(es)
|
2007-10-05 |
2010-08-10 |
Toray Industries |
Agente para aliviar problemas de la piel que comprende un derivado de morfinano o una sal de adicion de acido, farmacologicamente aceptable del mismo como ingrediente activo.
|
|
CN101412692B
(zh)
|
2007-10-18 |
2012-10-17 |
中国科学院上海药物研究所 |
1-(3-氨基丙基)哌啶-4-氨基酰胺类化合物、其药物组合物及其制备方法和用途
|
|
WO2009089508A1
(en)
|
2008-01-11 |
2009-07-16 |
The Regents Of The University Of California |
Activators of executioner procaspases 3, 6 and 7
|
|
WO2009112445A1
(en)
|
2008-03-10 |
2009-09-17 |
Novartis Ag |
Method of increasing cellular phosphatidyl choline by dgat1 inhibition
|
|
AU2009233711B2
(en)
|
2008-04-09 |
2015-02-12 |
Infinity Pharmaceuticals, Inc |
Inhibitors of fatty acid amide hydrolase
|
|
CN102083794A
(zh)
|
2008-05-05 |
2011-06-01 |
安姆根有限公司 |
作为γ分泌酶调节剂的脲化合物
|
|
CA2734500A1
(en)
|
2008-08-27 |
2010-03-11 |
Calcimedica Inc. |
Compounds that modulate intracellular calcium
|
|
CN101712679B
(zh)
|
2008-10-08 |
2013-04-10 |
中国科学院上海药物研究所 |
一种酰胺类化合物、其药物组合物及其制备方法和用途
|
|
CN102196811B
(zh)
|
2008-10-24 |
2014-03-19 |
东丽株式会社 |
含有4,5-环氧基吗啡烷衍生物的稳定片剂
|
|
JP5535931B2
(ja)
|
2008-10-27 |
2014-07-02 |
武田薬品工業株式会社 |
二環性化合物
|
|
GB0821913D0
(en)
|
2008-12-02 |
2009-01-07 |
Price & Co |
Antibacterial compounds
|
|
EP2774927A1
(en)
|
2008-12-03 |
2014-09-10 |
Presidio Pharmaceuticals, Inc. |
Inhibitors of HCV NS5A
|
|
WO2010088574A1
(en)
|
2009-01-30 |
2010-08-05 |
Sirtris Pharmaceuticals, Inc. |
Azabenzimidazoles and related analogs as sirtuin modulators
|
|
MX2011010132A
(es)
|
2009-03-27 |
2011-10-14 |
Presidio Pharmaceuticals Inc |
Inhibidores de anillo fusionado de hepatitis c.
|
|
EP2470533A4
(en)
|
2009-08-24 |
2013-01-23 |
Ascepion Pharmaceuticals Inc |
UREA COMPOUNDS CONTAINING A 5,6-BICYCLIC HETEROARYL GROUP
|
|
KR101781663B1
(ko)
|
2010-01-13 |
2017-09-25 |
템페로 파마슈티칼즈, 인크. |
히스톤 데아세틸라제 효소를 억제하기 위한 화합물 및 이를 제조하는 방법
|
|
MX362830B
(es)
|
2010-01-29 |
2019-02-14 |
Toray Industries |
Agente terapeutico o profilactico para enfermedades del tracto biliar.
|
|
JP2013536806A
(ja)
|
2010-09-01 |
2013-09-26 |
アスセピオン ファーマスーティカル、インコーポレイテッド |
キナーゼ阻害剤としての重水素化複素環式化合物
|
|
WO2012050918A2
(en)
|
2010-09-29 |
2012-04-19 |
Presidio Pharmaceutical, Inc. |
Tricyclic fused ring inhibitors of hepatitis c
|
|
ES2586655T3
(es)
|
2011-01-31 |
2016-10-18 |
Toray Industries, Inc. |
(-)-17-(ciclopropilmetil)-3,14beta-dihidroxi-4,5alfa-epoxi-6beta-[N-metil-trans-3-(3-furil)acrilamido]morfinano para su utilización en el tratamiento o prevención de la caquexia por cáncer
|
|
WO2012107475A1
(en)
|
2011-02-10 |
2012-08-16 |
Syngenta Participations Ag |
Microbiocidal pyrazole derivatives
|
|
WO2012129562A2
(en)
|
2011-03-24 |
2012-09-27 |
The Scripps Research Institute |
Compounds and methods for inducing chondrogenesis
|
|
US9282738B2
(en)
|
2011-07-11 |
2016-03-15 |
Wisconsin Alumni Research Foundation |
Antimicrobial compositions and methods of use thereof
|
|
WO2013009810A1
(en)
|
2011-07-13 |
2013-01-17 |
Tempero Pharmaceuticals, Inc. |
Methods of treatment
|
|
WO2013009830A1
(en)
|
2011-07-13 |
2013-01-17 |
Tempero Pharmaceuticals, Inc. |
Methods of treatment
|
|
CN104136429A
(zh)
|
2011-12-23 |
2014-11-05 |
诺华股份有限公司 |
用于抑制bcl2与结合配偶体相互作用的化合物
|
|
EP2803662B1
(en)
|
2012-01-13 |
2017-03-01 |
Nippon Chemiphar Co., Ltd. |
P2x4 receptor antagonist
|
|
DE102012103405A1
(de)
|
2012-04-18 |
2013-10-24 |
Heinrich-Pette-Institut |
Desoxyhypusin-Synthase-Inhibitoren
|
|
US20140200215A1
(en)
|
2013-01-15 |
2014-07-17 |
Intermune, Inc. |
Lysophosphatidic acid receptor antagonists
|
|
AU2014369053B2
(en)
|
2013-12-20 |
2019-03-14 |
Institute For Drug Discovery, Llc |
Substituted amino triazoles, and methods using same
|
|
KR20150136294A
(ko)
|
2014-05-27 |
2015-12-07 |
주식회사 레고켐 바이오사이언스 |
인자 ＸＩａ 억제 활성을 가지는 신규한 화합물
|
|
EP2993174A1
(en)
|
2014-09-08 |
2016-03-09 |
Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt GmbH |
Pyrazolopyridine derivatives and their use in therapy
|
|
JP6217866B2
(ja)
*
|
2014-10-24 |
2017-10-25 |
小野薬品工業株式会社 |
Ｋｃｎｑ２〜５チャネル活性化剤
|
|
WO2016172255A1
(en)
|
2015-04-21 |
2016-10-27 |
Allgenesis Biotherapeutics, Inc. |
Compounds and their use as bace1 inhibitors
|
|
WO2017039318A1
(en)
|
2015-09-01 |
2017-03-09 |
Kainos Medicine, Inc. |
Benzimidazole derivatives for dna methylation inhibitors
|
|
WO2017117447A1
(en)
|
2015-12-31 |
2017-07-06 |
Karyopharm Therapeutics Inc. |
Multicyclic compounds and uses thereof
|
|
EP3447045B9
(en)
*
|
2016-04-22 |
2021-07-21 |
ONO Pharmaceutical Co., Ltd. |
1-(1-hydroxy-2,3-dihydro-1h-inden-5-yl)-urea derivatives and related compounds kcnq 2-5 channel activators for treating dysuria
|
|
EA201892460A1
(ru)
|
2016-05-04 |
2019-09-30 |
Би.Си.Ай. ФАРМА |
Производные аденина как ингибиторы протеинкиназ
|
|
WO2018165501A1
(en)
|
2017-03-10 |
2018-09-13 |
Lycera Corporation |
INDOLINYL SULFONAMIDE AND RELATED COMPOUNDS FOR USE AS AGONISTS OF RORγ AND THE TREATMENT OF DISEASE
|
|
EP3621962A4
(en)
|
2017-05-10 |
2020-12-09 |
Forge Therapeutics, Inc. |
ANTIBACTERIAL COMPOUNDS
|
|
WO2019111225A1
(en)
|
2017-12-08 |
2019-06-13 |
Avaliv Therapeutics |
Compounds and methods for the treatment of non‑alcoholic steatohepatitis
|
|
GB201809050D0
(en)
|
2018-06-01 |
2018-07-18 |
E Therapeutics Plc |
Modulators of tryptophan catabolism
|
|
US12226400B2
(en)
|
2018-07-31 |
2025-02-18 |
University Of Pittsburgh-Of The Commonwealth System Of Higher Education |
Neuroprotective disruption of Kv2.1/syntaxin interaction by small molecules
|
|
CA3051422A1
(en)
|
2018-08-09 |
2020-02-09 |
Kineta, Inc. |
Activators of the retinoic acid inducible gene "rig-i" pathway and methods of use thereof
|
|
EP3841221A4
(en)
|
2018-08-23 |
2022-06-08 |
Memorial Sloan-Kettering Cancer Center |
BIOMARKERS TO DETERMINE CANCER SENSITIVITY TO PI3K INHIBITORS
|
|
JP7541483B2
(ja)
|
2018-09-03 |
2024-08-28 |
日本ケミファ株式会社 |
糖尿病性末梢神経障害のための医薬
|
|
CN111039942B
(zh)
|
2018-10-12 |
2023-04-14 |
上海长森药业有限公司 |
含氮杂环类化合物，及其制备方法、药物组合物和应用
|
|
EP3953350A1
(en)
|
2019-04-12 |
2022-02-16 |
The United States of America, as Represented by The Department of Health and Human Services |
D3 receptor agonist compounds; methods of preparation; intermediates thereof; and methods of use thereof
|
|
WO2020228649A1
(zh)
|
2019-05-10 |
2020-11-19 |
上海海雁医药科技有限公司 |
取代的苯基丙烯基吡啶类衍生物，其制法与医药上的用途
|
|
CR20230576A
(es)
|
2021-06-14 |
2024-04-05 |
Scorpion Therapeutics Inc |
Derivados de la urea que pueden ser utilizados para tratar el cáncer
|